SG3 Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,000
Closed -$325K 251
2022
Q3
$325K Buy
+10,000
New +$412K 0.04% 169
2020
Q1
Sell
-27,900
Closed -$2.58M 389
2019
Q4
$2.58M Sell
27,900
-2,100
-7% -$185K 0.16% 51
2019
Q3
$2.71M Buy
+30,000
New +$3.42M 0.25% 61

Other funds holding EXAS

SG3 Management's EXAS Position: Q1 2023 in Review

SG3 Management sold out of Exact Sciences (EXAS) in Q1 2023, closing a stake of 12,000 shares — an estimated $594K sold.

SG3 Management first reported a position in EXAS in Q1 2022 and held it in 2 quarters. The position peaked at $594K in Q4 2022. 583 funds tracked by Wall St. Rank hold EXAS as of Q1 2023.

  • SG3 Management reported no remaining Exact Sciences position as of Q1 2023 after selling out during the quarter.
  • SG3 Management sold 12,000 Exact Sciences shares in Q1 2023, an estimated $594K.
  • SG3 Management first reported a position in Exact Sciences in Q1 2022 and held it in 2 quarters.
  • SG3 Management's Exact Sciences position peaked at $594K in Q4 2022.
  • 583 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2023.

Based on SG3 Management's 13F filing for Q1 2023, filed 15 May 2023.